Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
about
Mitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesDynamic, large-scale profiling of transcription factor activity from live cells in 3D culture.Carbohydrate polymers for nonviral nucleic acid delivery.Polysaccharide-modified synthetic polymeric biomaterials.Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds.Two and three-dimensional gene transfer from enzymatically degradable hydrogel scaffoldsIncorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds.Preparation and characterization of gelatin-based mucoadhesive nanocomposites as intravesical gene delivery scaffoldsHyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery.Encapsulation of PEGylated low-molecular-weight PEI polyplexes in hyaluronic acid hydrogels reduces aggregation.Matrices and scaffolds for DNA delivery in tissue engineeringHyaluronic acid hydrogels for biomedical applications.DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells.Digoxigenin modification of adenovirus to spatially control gene delivery from chitosan surfacesVirus-mimetic cytoplasm-cleavable magnetic/silica nanoclusters for enhanced gene delivery to mesenchymal stem cellsNon-viral DNA delivery from porous hyaluronic acid hydrogels in mice.Drug delivery in soft tissue engineering.Messenger RNA (mRNA) nanoparticle tumour vaccinationHydrogel doped with nanoparticles for local sustained release of siRNA in breast cancer.Polyelectrolyte multilayer coating of 3D scaffolds enhances tissue growth and gene delivery: non-invasive and label-free assessment.Using glucosamine to improve the properties of photocrosslinked gelatin scaffolds.Direct synthesis of biodegradable polysaccharide derivative hydrogels through aqueous Diels-Alder chemistry.Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels.Biocompatible carbon nanotube-chitosan scaffold matching the electrical conductivity of the heart.Novel multiarm PEG-based hydrogels for tissue engineering.Design and characterization of microporous hyaluronic acid hydrogels for in vitro gene transfer to mMSCs.Poloxamine/fibrin hybrid hydrogels for non-viral gene delivery.Balancing cell migration with matrix degradation enhances gene delivery to cells cultured three-dimensionally within hydrogels.Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering.Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering.Controlled gelation and degradation rates of injectable hyaluronic acid-based hydrogels through a double crosslinking strategy.Enhanced cardioprotective effects mediated by plasmid containing the short-hairpin RNA of angiotensin converting enzyme with a biodegradable hydrogel after myocardial infarction.Exogenous miR-29B Delivery Through a Hyaluronan-Based Injectable System Yields Functional Maintenance of the Infarcted Myocardium.Poly(γ-glutamic acid) modulates the properties of poly(ethylene glycol) hydrogel for biomedical applications.Application of Polyethylenimine-Grafted Silicon Nanowire Arrays for Gene Transfection.Injectable, Biodegradable Hydrogels for Tissue Engineering Applications.Hyaluronic acid hydrogel scaffolds loaded with cationic niosomes for efficient non-viral gene deliveryApplication of Hydrogel Biocomposites for Multiple Drug DeliveryHydrogels as drug-delivery platforms: physicochemical barriers and solutions
P2860
Q28294355-16E03685-0E0A-4C68-A6A0-A4CB4709E799Q33754562-33354563-7572-4790-8CDF-804607FC6493Q33897565-28B8EB16-6A83-4396-A4ED-24A497DA9005Q33978402-F9447B00-916A-42A9-A18A-02AC67301DEDQ34082344-373718FC-B170-4C30-8D4B-677AD04571F2Q34091796-3201D82E-56E2-4BED-B27B-F9642F7ECCE1Q34474842-B083E159-8EF9-4300-B15D-29BE85B34742Q34785672-6C65F7B2-42D1-449C-BD40-E7135971AC7BQ35112949-0312D05D-2BB2-4054-BB46-6DD6D798B8B5Q36289111-1072D2A6-2119-488B-93DE-1F2D4DC5A7B4Q36826532-E3FA161C-8EB4-48CE-BC6C-E7EE1921E78EQ37063026-1556C6AC-11D2-4B15-9433-711FA8911973Q37095873-569689B7-4D56-4857-8F6D-ECE0B27611A4Q37157728-EE9C671E-2FCE-4005-A077-7F39C794F0BAQ37352200-78F283EB-1F28-4464-89F4-B987ECF3F200Q37615651-3BD7E4E5-BCB4-4D08-9403-0D2D92798CB9Q37890406-8DCE211E-AE4C-4F2B-9F45-490C31730357Q38218147-972E8389-FD43-4885-B3D2-BB9A5C29AD75Q38967041-73CEF7F1-9B8A-41FC-92BA-0E07133B7EDDQ39096569-FE903B79-568E-48AC-B102-BFE12F91DB33Q39124560-A41826BB-E19E-4720-A3AC-747352AFEFF0Q39552719-507D1B10-7002-4913-AD1A-3DF187DF39C1Q41628734-52E59721-85E8-4E65-B69E-43005BFEFE4BQ41771315-A597117F-C73C-4134-AD7B-E106FD03A45EQ41849228-F1F95779-0810-4AEF-9C27-6826E54E0642Q42026730-863D436C-AF50-4DFD-8A16-52E0B46FA7B1Q42110886-864ED6ED-A344-4B1E-B07A-B6607B4CB3B9Q42215078-21FCB397-D6AC-4FCC-B4FE-DD94000FF23AQ42285059-40174D06-7AFA-43F9-B21C-8886755FE7DDQ42673344-8F5EE4AB-4C3E-4AA7-ABB2-6080DDC667A6Q42740469-2F041759-226A-47B8-88B7-3FD16624393BQ42751663-4F7468A4-2EEE-45DB-A2B1-E5FCD7D192E2Q43415032-9AA10F56-4BD4-41F6-A7B2-289179591D00Q45957668-0D5D1101-E007-45CC-93D7-4AD45FF7D3A9Q51172328-67C454B7-9922-4376-A91E-EB719A781C40Q51241776-DD11FC70-E427-4DB0-B18C-B82076504555Q54594736-D891C0DE-F160-47C2-8481-FF007CCB4A12Q57192067-47B9264C-91CC-4A7D-AD50-0D50527D8E63Q57341164-DFC61267-231D-44B1-AC36-84D754ED8BB2Q57383610-137B4324-3DC5-4FD6-AB45-2F0B9F775549
P2860
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
@en
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
@nl
type
label
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
@en
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
@nl
prefLabel
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
@en
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
@nl
P2093
P2860
P1476
Non-viral vector delivery from PEG-hyaluronic acid hydrogels.
@en
P2093
Julie A Wieland
Lonnie D Shea
Tiffany L Houchin-Ray
P2860
P304
P356
10.1016/J.JCONREL.2007.04.015
P407
P577
2007-05-01T00:00:00Z